Abbott Laboratories Stock (ABT) Dips 2% on Spinoff Plans for Abbott Nutrition
Abbott Laboratories stock was down over 2% on plans to spinoff its nutrition business into a separate public company.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 98,271 | $9,712,076 | -2% | 0.52% |
| 2. | Bailard Inc Thomas Bailard | 83,131 | $8,215,868 | -1% | 0.17% |
| 3. | Sivik Global Healthcare Krishen Sud | 55,000 | $5,435,650 | +120% | 3.11% |
| 4. | Zevenbergen Capital Investments Nancy Zevenbergen | 19,049 | $1,882,613 | -1% | 0.04% |
| 5. | Bourgeon Capital John Zaro | 3,330 | $329,118 | +1% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.82 | 2,000 | $173,640.00 | 23,319 | 2026-05-07 | Filing | |
| $92.65 | 10,000 | $926,537.00 | 6,751,103 | 2026-04-27 | Filing | |
| $91.50 | 2,200 | $201,300.00 | 2,200 | 2026-04-23 | Filing | |
| $108.33 | 5,033 | $545,238.98 | 6,738,817 | 2026-02-04 | Filing | |
| $109.14 | 4,967 | $542,092.42 | 6,733,784 | 2026-02-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $109.54 | 27 | $2,957.58 | 24,549 | 2026-09-02 | Filing | |
| $116.19 | 180,297 | $20,948,708.43 | 306,461 | 2026-08-25 | Filing | |
| $115.57 | 218,535 | $25,256,089.95 | 486,758 | 2026-08-25 | Filing | |
| $109.83 | 5,850 | $642,505.50 | 70,724 | 2026-08-11 | Filing | |
| $115.58 | 709 | $81,946.22 | 39,164 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,187,488 | $512,679,439 | 0.5% | |
| 2. | 1,812,141 | $180,098,991 | 0.91% | |
| 3. | 1,793,214 | $177,223,346 | 0.39% | |
| 4. | 1,530,620 | $151,271,412 | 1.4% | |
| 5. | 1,456,019 | $137,394,375 | 0.2% |
News See All
Abbott Laboratories Stock (ABT) Plunges 4% as It Separates $8.5B Nutrition Business
Shares in Abbott Laboratories ($ABT) were down 4% in pre-market trading today as it announced that it planned to separate its global Nutrition busi...
Options Volatility and Implied Earnings Moves Today, October 21, 2026
Today, several major companies are expected to report earnings: Abbott Laboratories (ABT), AT&T (T), Meta Platforms (META), International Business ...
Abbott Labs’ (ABT) Solid Financial Beat Signals Long EPS Growth and Dividend Safety
Longleaf Partners, managed by Southeastern Asset Management, released its third-quarter 2026 investor letter for its “Partners Fund”. The letter can be downloaded here.
Abbott (ABT): Can Libre Keep Growing as Glucose Monitoring Becomes More Competitive?
Abbott Laboratories (NYSE:ABT) benefits each time a patient replaces a glucose sensor.
Options Volatility and Implied Earnings Moves This Week, October 20 – October 23, 2026
This week, several major companies will be reporting earnings. Among them are Tesla (TSLA), Meta Platforms (META), Netflix (NFLX), AT&T (T), GE Aer...
Trump’s Latest Stock Portfolio: 10 Stocks to Buy
President Donald Trump’s stock trades have set off a frenzy of disclosures this year, and they are gaining attention in the debate over what a president should be allowed to own.
Billionaires and Trump Were Buying This Healthcare Stock
Abbott Laboratories (NYSE:ABT) is one of the top 10 picks in President Trump’s latest stock portfolio. Trump bought $1 million to $5 million of Abbott in August.
The Week That Was, The Week Ahead: Macro and Markets, October 18
U.S. stocks finished Friday sharply lower as a broad selloff in AI and technology shares dragged the Nasdaq to its worst week since June. The Dow J...
The Week That Was, The Week Ahead: Macro and Markets, October 11
U.S. stocks finished Friday higher, recovering from a technology selloff sparked by questions over OpenAI’s revenue figures. The Dow Jones Industri...
Hedge Fund Resource Center